186 related articles for article (PubMed ID: 6339286)
21. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group.
Drake LA; Millikan LE
Arch Dermatol; 1995 Dec; 131(12):1403-8. PubMed ID: 7492129
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and Safety of Halometasone Cream to Treat Chronic Generalized Eczema and the Effects of Halometasone Cream on Serum Cortisol Levels.
Li Y; Xu W; Li L
Biomed Res Int; 2017; 2017():3265024. PubMed ID: 29250537
[TBL] [Abstract][Full Text] [Related]
23. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
Gomez EC; Kaminester L; Frost P
Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study.
Faghihi G; Iraji F; Shahingohar A; Saidat A
J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511
[TBL] [Abstract][Full Text] [Related]
25. [Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution].
Nolting S; Hagemeier HH
Fortschr Med; 1983 Oct; 101(37):1679-83. PubMed ID: 6227542
[TBL] [Abstract][Full Text] [Related]
26. A double-blind controlled evaluation of Diproderm cream 0.05%, twice a day treatment in comparison with once a day treatment in eczema.
Gärtner L; Tarras-Wahlberg C
J Int Med Res; 1984; 12(1):59-61. PubMed ID: 6363158
[TBL] [Abstract][Full Text] [Related]
27. A double-blind comparison of the efficacy of betamethasone dipropionate cream twice daily versus once daily in the treatment of steroid responsive dermatoses.
English JS; Bunker CB; Ruthven K; Dowd PM; Greaves MW
Clin Exp Dermatol; 1989 Jan; 14(1):32-4. PubMed ID: 2680178
[TBL] [Abstract][Full Text] [Related]
28. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
Molin L; Cutler TP; Helander I; Nyfors B; Downes N
Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
[TBL] [Abstract][Full Text] [Related]
30. Management of eczematous dermatitis with amcinonide or betamethasone valerate. A double-blind comparative study.
Rosenberg EW
Cutis; 1979 Dec; 24(6):642-5. PubMed ID: 391500
[TBL] [Abstract][Full Text] [Related]
31. Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitis.
Yawalkar SJ; Schwerzmann L
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1163-6. PubMed ID: 1757610
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy and safety of topical 0.05% diflorasone diacetate (florone) cream/ointment in patients with acute/chronic dermatitis].
Schneider WD
Z Hautkr; 1984 Oct; 59(19):1312, 1319-22. PubMed ID: 6391003
[TBL] [Abstract][Full Text] [Related]
33. Clinical investigation of halopredone acetate, a new topical steroid, in dermatology. Controlled study.
Palmerio B; Magnani P
Arzneimittelforschung; 1977; 27(12):2404-6. PubMed ID: 341905
[TBL] [Abstract][Full Text] [Related]
34. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part II: Comparative study with several commercial preparations (author's transl)].
Reckers VR; Wendt H
Arzneimittelforschung; 1976; 26(7b):1504-9. PubMed ID: 795434
[TBL] [Abstract][Full Text] [Related]
35. Treatment of infected dermatoses: a randomized, double-blind clinical trial in general practice.
Vallé-Jones JC
Pharmatherapeutica; 1980; 2(5):293-5. PubMed ID: 7001488
[TBL] [Abstract][Full Text] [Related]
36. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
37. [Fluticasone propionate, corticosteroid for topical treatment].
Neumann E; Raszeja-Kotelba B
Pol Merkur Lekarski; 1998 Feb; 4(20):92-3. PubMed ID: 9591441
[TBL] [Abstract][Full Text] [Related]
38. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
Hon KL; Tsang YC; Pong NH; Lee VW; Luk NM; Chow CM; Leung TF
Hong Kong Med J; 2015 Oct; 21(5):417-25. PubMed ID: 26314567
[TBL] [Abstract][Full Text] [Related]
39. Fusidic acid plus betamethasone in infected or potentially infected eczema.
Hjorth N; Schmidt H; Thomsen K
Pharmatherapeutica; 1985; 4(2):126-31. PubMed ID: 3903779
[TBL] [Abstract][Full Text] [Related]
40. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
